✦ LIBER ✦

Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis

✍ Scribed by Joachim Havla, Björn Tackenberg, Kerstin Hellwig, Ingrid Meinl…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

De-escalation from natalizumab in multip

✍ Joachim Havla; Lisa Ann Gerdes; Ingrid Meinl; Markus Krumbholz; Hans Faber; Fran 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 217 KB

PND38 Cost Minimization Analysis of Fing

✍ Crespo, C.; Izquierdo, G.; García-Ruiz, A.; Granell, M.; Brosa, M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Oral laquinimod reduces disease activity

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Multiple sclerosis: Disease activity is

✍ Bible, Ellen 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 531 KB

Predictors of freedom from disease activ

✍ Luca Prosperini; Costanza Giannì; Valeria Barletta; Chiara Mancinelli; Federica 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 732 KB

Efficacy of natalizumab in multiple scle

✍ A. B. Oturai; N. Koch-Henriksen; T. Petersen; P. E. H. Jensen; F. Sellebjerg; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB